Skip to main content

Table 2 Clinical trials of CC-220

From: Novel immunomodulatory drugs and neo-substrates

Phase

Conditions

Interventions

NCT ID

1

Healthy volunteers

CC-220, placebo

NCT01733875

2

SLE

CC-220, placebo

NCT03161483

2

SLE

CC-220, placebo

NCT02185040

1,2

MM

CC-220, DEX, Dara, BTZ

NCT02773030

1

Healthy volunteers

CC-220

NCT03135509

1

Healthy volunteers

CC-220, radiation

NCT03294603

1

Hepatic impairment, Healthy volunteers

CC-220

NCT03824678

  1. Abbreviation: SLE Systemic lupus erythematosus, DEX Dexamethasone, Dara Daratumumab, BTZ Bortezomib